Clinical Trial: Body Weight Changes After Switching to Lurasidone for Antipsychotic-induced Weight Gain in Bipolar Disorder: a Multicenter Retrospective Study of Selected Follow-up Cohort

U.S., Sept. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07834112) titled 'Body Weight Changes After Switching to Lurasidone for Antipsychotic-induced Weight Gain in Bipolar Disorder: a Multicenter Retrospective Study of Selected Follow-up Cohort' on Sept. 16.

Brief Summary: Study Objective: To evaluate the treatment effectiveness and safety by analyzing prescription patterns in a routine clinical practice setting and observing changes in clinical indicators (weight, BMI, HAM-D, CGI-S, CGI-I) among patients prescribed Lurasidone for the treatment of bipolar disorder.

Study Design: Retrospective, Multi-center, Investigator-Initiated Observational Study.

Study Start Date: Sept. 09, 2024

Study Type: OBSER...